New! Sign up for our email newsletter on Substack.

How NOV-002 treatment leads to gene expression

HOW NOV-002 treatment leads to gene expression changes in SKOV3 cancer cell lines
———-

NADPH oxidase genes are up-regulated by chronic NOV-002 treatment in SKOV3 cells

NOX5 – 13.3 fold NADPH oxidase, EF calcium binding domain 5
– produces superoxide
– activated by calcium

CYBA – 2.1 fold – Cytochrome b-245 alpha polypeptide; p22 PHOX
– 22 KD subunit of NADPH oxidase
– produces superoxide anion

NCF – 2.1 fold – Neutrophil cytosolic factor 1: p47 PHOX; NOX02
– 67 KD subunit of NADPH oxidase
– produces superoxide anion
———————————–
Other genes that are up-regulated by chronic NOV-002 treatment in SKOV3 cells

IL8 – 39 fold – interleukin 8
– CXC chemokine; medicator of inflammatory response
– Chemoatrractrant and angiogenic factor
– Induced by oxidative stress

VEGFA – 3.5 fold – Vascular endothelial growth factor A
– Angiogenic factor
– Induced by oxidative stress
– Activates NADPH oxidase resulting in superoxide production

JUN – 1.8 fold – Jun oncogenes
– Activation can lead to Apoptosis

Fuel Independent Science Reporting: Make a Difference Today

If our reporting has informed or inspired you, please consider making a donation. Every contribution, no matter the size, empowers us to continue delivering accurate, engaging, and trustworthy science and medical news. Independent journalism requires time, effort, and resources—your support ensures we can keep uncovering the stories that matter most to you.

Join us in making knowledge accessible and impactful. Thank you for standing with us!



Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.